Abstract

PDB38 - Cost Consequence Analysis of Sitagliptin +Metformin Vs Sulfonylureas+Metformin in Type 2 Diabetic Patients in Italy

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call